MRI in Cervix and Endometrial Cancer

Size: px
Start display at page:

Download "MRI in Cervix and Endometrial Cancer"

Transcription

1 28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK

2 Objectives Cervix and endometrial cancer What it looks like on MRI What matters To the surgeon To the clinical oncologist To the radiologist! To the patient!!

3 Carcinoma of the Cervix Traditionally FIGO Staging System based on clinical examination Introduced in revisions since Most recently 2009 But Inaccurate Clinical staging errors in up to 25% of Stage I and Stage II disease Up to 67% in Stage II IV Underestimation in 25 67% Overestimation in 2%

4 Carcinoma of the Cervix Stage of disease has a profound influence on treatment options available to the patient Fertility sparing vs. radical surgery Surgical vs. non-surgical management Radical vs. palliative intent

5 MRI and Carcinoma of the Cervix Established evidence base for the use of MRI Provides sufficient information for management decision making Revised FIGO staging influenced by imaging findings Accuracy SubakL et al. ObstetGynecol 1995;86:43-39 Cost effective HricakH et al. Radiology 1996;198:

6 2009 FIGO Staging Stage I Tumour confined to cervix IA Micro invasive IB Clinically invasive Stage II tumour extension beyond cervix but not to pelvic sidewall IIA involvement of upper 2/3rds of vagina IIB parametrial invasion

7 MRI and Gynaecological malignancy Inherent soft tissue contrast of T2W MRI See intrinsic anatomy of uterine body and cervix Identify pathology

8 MRI and Carcinoma of the Cervix Increased fibrous tissue in the normal cervical stroma Lower signal intensity than myometrium on T2W Tumour visible as increased SI against the low SI stroma

9 MRI and Carcinoma of the Cervix Increased fibrous tissue in the normal cervical stroma Lower signal intensity than myometrium on T2W Tumour visible as increased SI against the low SI stroma

10 MRI and Carcinoma of the Cervix Squamous carcinoma occurs at the squamocolumnar junction Pre-menopausal women at the level of the ectocervix Tumours often exophytic

11 MRI and Carcinoma of the Cervix Post menopausal status Junction migrates up the endocervical canal Tumours grow superiorly into the uterine body May obstruct the endometrial cavity

12 MRI and Carcinoma of the Cervix Post menopausal status Junction migrates up the endocervical canal Tumours grow superiorly into the uterine body May obstruct the endometrial cavity

13 What information is needed from MRI in Cervical Cancer?

14 ? Surgery -1 Is the disease confined to the cervix? Avoid inappropriate surgery for advanced disease Not deny suitable patients curative surgical option

15 ? Surgery -1 Is the disease confined to the cervix? Is there an intact stromal ring?

16 ? Surgery -1 Intact stromal ring Negative predictive value Intact stromal ring has a high (95%) negative predictive value for parametrial invasion SubekLL et al, Obstet Gynecol 1995

17 Tumour size? Independent poor prognostic factor Failure of local disease control with increasing tumour size Perez CA et al. Cancer; 1992: MRI can give an accurate assessment of tumour dimensions and volume? Surgery -2

18 ? Surgery -2 Tumour size Independent poor prognostic factor Recognised in new FIGO Staging Stage IB clinically visible lesion IB1 -<4cm IB2 -> 4cm Stage IIA FIGO 2009 IIA1 -<4cm IIA2 -> 4cm

19 ? Surgery -3 Are there nodal metastases? Not included in FIGO staging Profound influence on treatment strategy Poor prognostic factor

20 Nodal disease MRI = CT Accuracies ~ 85 90% Low sensitivity 43 73% Inability to identify metastases in normal sized nodes

21 Nodal disease Size Other features Extracapsular extension Central necrosis Obstruction

22 Nodal disease Size Other features Extracapsular extension Central necrosis Obstruction PET CT

23 Non-surgical management Chemo-radiotherapy Concurrent chemotherapy and external beam radiotherapy 3 x intracavitary brachytherapy

24 Non-surgical management Aim to deliver a tumouricidaldose of radiation to a well defined target volume Spare surrounding normal tissue Curative or palliative intent

25 Radiotherapy Volumes CTV GTV PTV

26 CTV GTV PTV Irradiated Volume

27 External Beam Radiotherapy

28 What does the Radiation Oncologist Anatomical detail want to know -1 Where exactly is the tumour? Accurate delineation of the GTV CT planned Need bony and tissue electron density information

29 What does the Radiation Oncologist Tumour size want to know -2 Particularly craniocaudal extent Planning intracavitary treatment

30 What does the Radiation Oncologist Tumour size want to know -2 Particularly craniocaudal extent Planning intracavitary treatment

31 What does the Radiation Oncologist Is there vaginal involvement want to know -3 What is the inferior extent? Affects RT volumes GTV and CTV

32 What does the Radiation Oncologist Is there vaginal involvement want to know -3 What is the inferior extent? Affects RT volumes GTV and CTV

33 What does the Radiation Oncologist want to know -4 Where are the nodal metastases? Significant impact on management planning Nodal GTV and CTV Node negative on MR - external iliac level ~ L5/S1 Node positive -one level above the positive nodes Inguinal nodes if macroscopic lesion in lower third of the vagina

34 MRI and Carcinoma of the Cervix Central role in patient assessment In most patients, in conjunction with clinical status, MRI alone provides sufficient information for decisions to be made about case management

35 MRI and Endometrial Cancer More contentious than the use of MRI in Cervical Cancer Grade 1& 2, stage 1A disease Hysterectomy Surgery is the primary treatment modality Extent of surgery depends on pathology and tumour stage Grade 3 all stages and Grade 1 & 2 stage >1B Lymphadenectomy

36 MRI and Endometrial Cancer Why? Stage disease Select patients who at risk of relapse for more radical surgery Plan adjuvant treatment Avoid over treating lowrisk patients

37 MRI and Endometrial Cancer Depth of myometrial invasion Prognostic information Correlates Tumour grade Cervix involvement Likelihood of nodal metastases

38 How good is MRI for assessing depth of Radiology literature reports accuracy between 55 77% for T2W images invasion? 85 91% for dynamic contrast enhanced images KinkelK et al Radiology 1999 FreiK et al Radiology 2000

39 Involvement of the Cervix Reported accuracy of MRI in detecting cervical invasion up to 92% Sensitivities of 75 80% Specificities of 94 96% Adjuvant RT

40 Peritoneal disease Not a contraindication to surgery Identify preoperatively Need chemotherapy

41 Uterine Dimensions Assess suitability for laparoscopicallyassisted vaginal hysterectomy (LAVH)

42 Limitations of MRI Myometrialthinning by bulky tumours Cornual regions Coexisting benign pathology Difficult to assess depth of invasion

43 Coexisting benign pathologies Adenomyosis

44 Coexisting benign pathologies Cystic Adenomyosis

45 Coexisting benign pathologies Leiomyomata Distort uterine anatomy

46 What do wewant the Surgeons and Heterogeneous polypoidmass on T2W images Progressive enhancement post contrast Oncologists to know?! Think sarcoma

47 What do we want the Surgeons and Oncologists to know?! Lesions which prolapse down into the cervix and vagina Uterine inversion Think sarcoma

48 MRI for Cervix and Endometrial Demonstrates and stage the disease Cancers Can answer the questions that are needed to plan patient management

49 Thank you

Staging and Treatment Update for Gynecologic Malignancies

Staging and Treatment Update for Gynecologic Malignancies Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths

More information

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion 5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND

More information

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April

More information

Enterprise Interest None

Enterprise Interest None Enterprise Interest None Cervical Cancer -Management of late stages ESP meeting Bilbao Spain 2018 Dr Mary McCormack PhD FRCR Consultant Clinical Oncologist University College Hospital London On behalf

More information

Adjuvant Therapies in Endometrial Cancer. Emma Hudson

Adjuvant Therapies in Endometrial Cancer. Emma Hudson Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial

More information

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital: May 2016 Randomisation Checklist Form 1, page 1 of 2 Patient seqnr. Age at inclusion (years) Hospital: Eligible patients should be registered and randomised via the Internet at : https://prod.tenalea.net/fs4/dm/delogin.aspx?refererpath=dehome.aspx

More information

Coversheet for Network Site Specific Group Agreed Documentation

Coversheet for Network Site Specific Group Agreed Documentation Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance

More information

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms

More information

MRI for cervical and endometrial cancers. Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB

MRI for cervical and endometrial cancers. Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB MRI for cervical and endometrial cancers Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB RCR 06(1) RCR 06(1) Technique Pelvic multiphased-array coil Fasting? Buscopan? ABDOMEN!!! Cx:+/- HR

More information

Cervical Cancer: 2018 FIGO Staging

Cervical Cancer: 2018 FIGO Staging Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford

More information

Vaginal intraepithelial neoplasia

Vaginal intraepithelial neoplasia Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the

More information

Endometrial Cancer. Incidence. Types 3/25/2019

Endometrial Cancer. Incidence. Types 3/25/2019 Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy

More information

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data David Cibula Gynecologic Oncology Centre General University Hospital

More information

17 th ESO-ESMO Masterclass in clinical Oncology

17 th ESO-ESMO Masterclass in clinical Oncology 17 th ESO-ESMO Masterclass in clinical Oncology Cervical and endometrial Cancer Cristiana Sessa IOSI Bellinzona, Switzerland Berlin, March 28 th, 2018 Presenter Disclosures None Cervical Cancer Estimated

More information

JMSCR Vol 05 Issue 06 Page June 2017

JMSCR Vol 05 Issue 06 Page June 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i6.29 MRI in Clinically Suspected Uterine and

More information

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%

More information

Janjira Petsuksiri, M.D

Janjira Petsuksiri, M.D GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors

More information

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?

More information

GYNECOLOGIC CANCER and RADIATION THERAPY. Jon Anders M.D. Radiation Oncology

GYNECOLOGIC CANCER and RADIATION THERAPY. Jon Anders M.D. Radiation Oncology GYNECOLOGIC CANCER and RADIATION THERAPY Jon Anders M.D. Radiation Oncology Brachytherapy Comes from the Greek brakhus meaning short Brachytherapy is treatment at short distance Intracavitary vs interstitial

More information

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป Brachytherapy การร กษาด วยร งส ระยะใกล Insertion การสอดใส แร Implantation การฝ งแร Surface application การวางแร physical benefit of brachytherapy - very high dose of radiation

More information

Algorithms for management of Cervical cancer

Algorithms for management of Cervical cancer Algithms f management of Cervical cancer Algithms f management of cervical cancer are based on existing protocols and guidelines within the ESGO comunity and prepared by ESGO Educational Committe as a

More information

receive adjuvant chemotherapy

receive adjuvant chemotherapy Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer

More information

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT

More information

The new FIGO classification in endometrial carcinoma

The new FIGO classification in endometrial carcinoma The new FIGO classification in endometrial carcinoma Poster No.: C-1073 Congress: ECR 2012 Type: Educational Exhibit Authors: A. IGLESIAS CASTAÑON, M. Arias Gonzales, J. Mañas Uxó, 1 2 1 2 2 2 B. NIETO

More information

Gynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.

Gynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings. Management of Cervical Cancer in Resource Limited Settings Linus Chuang MD Conflict of Interests None Cervical cancer is the fourth most common malignancy in women worldwide 530,000 new cases per year

More information

ARROCase: Locally Advanced Endometrial Cancer

ARROCase: Locally Advanced Endometrial Cancer ARROCase: Locally Advanced Endometrial Cancer Charles Vu, MD (PGY-3) Faculty Advisor: Peter Y. Chen, MD, FACR Beaumont Health (Royal Oak, MI) November 2016 Case 62yo female with a 3yr history of vaginal

More information

Outline - MRI - CT - US. - Combinations of imaging modalities for treatment planning

Outline - MRI - CT - US. - Combinations of imaging modalities for treatment planning Imaging Outline - MRI - CT - US - Combinations of imaging modalities for treatment planning Imaging Part 1: MRI MRI for cervical cancer high soft tissue contrast multiplanar imaging MRI anatomy: the normal

More information

Cervical Cancer Guidelines L and SC Network July Introduction:

Cervical Cancer Guidelines L and SC Network July Introduction: Cervical Cancer Guidelines L and SC Network July 2018 Introduction: There was a total number of 442 cases of cervix cancer diagnosed in Lancashire and South Cumbria Cancer Network in the period 2005 2009

More information

Nordic Society for Gynecological Oncology Advisory Board of Radiotherapy

Nordic Society for Gynecological Oncology Advisory Board of Radiotherapy Nordic Society for Gynecological Oncology Advisory Board of Radiotherapy Guidelines for postoperative irradiation of cervical cancer Contents: 1. Treatment planning for EBRT. 2 2. Target definition for

More information

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on? MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion

More information

SCBT.MR MRI of Uterine Malignancy. Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC

SCBT.MR MRI of Uterine Malignancy. Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC 2 0 1 6 SCBT.MR MRI of Uterine Malignancy Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC aschers@gunet.georgetown.edu MUST READS Sala E, et al. The added role of

More information

Chapter 8 Adenocarcinoma

Chapter 8 Adenocarcinoma Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted

More information

Imaging of endometrial and cervical cancer

Imaging of endometrial and cervical cancer Insights Imaging (2010) 1:309 328 DOI 10.1007/s13244-010-0042-7 REVIEW Imaging of endometrial and cervical cancer Shilpa Patel & Sidath H. Liyanage & Anju Sahdev & Andrea G. Rockall & Rodney H. Reznek

More information

Case Scenario 1. History

Case Scenario 1. History History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family

More information

CARCINOMA CERVIX. Dr. PREETHI REDDY. B. M S OBG II yr POST GRADUATE.

CARCINOMA CERVIX. Dr. PREETHI REDDY. B. M S OBG II yr POST GRADUATE. CARCINOMA CERVIX Dr. PREETHI REDDY. B M S OBG II yr POST GRADUATE. Introduction Cervical cancer is the second most common female malignancy worldwide. It is responsible for 4,66,000 deaths annually worldwide

More information

Guideline for the Management of Vulval Cancer

Guideline for the Management of Vulval Cancer Version History Guideline for the Management of Vulval Cancer Version Date Brief Summary of Change Issued 2.0 20.02.08 Endorsed by the Governance Committee 2.1 19.11.10 Circulated at NSSG meeting 2.2 13.04.11

More information

UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER

UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER Susan Davidson, MD Professor Department of Obstetrics and Gynecology Division of Gynecologic Oncology University of Colorado- Denver Anatomy Review

More information

Cervical cancer presentation

Cervical cancer presentation Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000

More information

The International Federation of Gynecology and Obstetrics (FIGO) updated the staging

The International Federation of Gynecology and Obstetrics (FIGO) updated the staging Continuing Education Column Revised FIGO Staging System Hee Sug Ryu, MD Department of Obstetrics and Gynecology, Ajou University School of Medicine E - mail : hsryu@ajou.ac.kr J Korean Med Assoc 2010;

More information

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE) ESTRO Teaching Course on Image-guided radiotherapy & chemotherapy in gynaecological cancer - With a special focus on adaptive brachytherapy Prague, Czech Republic 22-26 October 2016 Course Directors: Richard

More information

Adnexal Masses and Problem Solving Pelvic MRI

Adnexal Masses and Problem Solving Pelvic MRI 28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 Adnexal Masses and Problem Solving Pelvic MRI DrSarah Swift St James s University Hospital Leeds, UK Objectives Characterisation

More information

Prognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis

Prognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis NJOG 2009 June-July; 4 (1): 19-24 Prognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis Eliza Shrestha 1, Xiong Ying 1,2, Liang Li-Zhi 1,2, Zheng Min 1,2,

More information

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas) CLINICAL C ORPUS UTERI C ARCINOMA STAGING FORM PATHOLOGIC Extent of disease before S TAGE C ATEGORY D EFINITIONS Extent of disease through any treatment completion of definitive surgery y clinical staging

More information

One of the commonest gynecological cancers,especially in white Americans.

One of the commonest gynecological cancers,especially in white Americans. Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in

More information

https://patient.varian.com/sit es/default/files/videos/origin al/imrt.mp4 brachy- from Greek brakhys "short" Historically LDR has been used. Cs-137 at 0.4-0.8 Gy/h With optimally placed device, dose

More information

Course Directors : Teaching Staff : Guest Lecturer: Local Organiser: ESTRO coordinators: Melissa Vanderijst and Marta Jayes, project managers (BEL)

Course Directors : Teaching Staff : Guest Lecturer: Local Organiser: ESTRO coordinators: Melissa Vanderijst and Marta Jayes, project managers (BEL) ESTRO Teaching Course on Image-guided radiotherapy & chemotherapy in gynaecological cancer - With a special focus on adaptive brachytherapy Florence, Italy 28 September -2 October 2014 Course Directors

More information

NAACCR Webinar Series /7/17

NAACCR Webinar Series /7/17 COLLECTING CANCER DATA: UTERUS 2017 2018 NAACCR WEBINAR SERIES Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

Role and Techniques of Surgery in Carcinoma Cervix. Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh

Role and Techniques of Surgery in Carcinoma Cervix. Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh Role and Techniques of Surgery in Carcinoma Cervix Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh Points for Discussion Pattern of spread Therapeutic options Types of surgical procedures

More information

The Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD

The Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD The Role of Radiation in the Management of Gynecologic Cancers Scott Glaser, MD Nothing to disclose DISCLOSURE Outline The role of radiation in: Endometrial Cancer Adjuvant Medically inoperable Cervical

More information

MANAGEMENT OF CERVICAL CANCER

MANAGEMENT OF CERVICAL CANCER MANAGEMENT OF CERVICAL CANCER Dr. Ujeen Shrestha Malla* and Prof. Dr. Zhang Shui Rong Department of Obstetrics and Gynaecology, Clinical Medical College of Yangtze University, Jingzhou Central Hospital,

More information

PET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp

PET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp PET/CT in Gynaecological Cancers Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp Cervix cancer Outline of this talk Initial staging Treatment monitoring/guidance

More information

Magnetic Resonance Imaging in Carcinoma of Cervix

Magnetic Resonance Imaging in Carcinoma of Cervix IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 9 Ver. 3 (September. 2018), PP 23-29 www.iosrjournals.org Dr. Mahak Sood, Dr. Ankita Boricha,

More information

Type I. Type II. Excess estrogen Lynch Endometrioid adenocarcinoma PTEN. High grade More aggressive Serous, Clear Cell p53

Type I. Type II. Excess estrogen Lynch Endometrioid adenocarcinoma PTEN. High grade More aggressive Serous, Clear Cell p53 Type I Excess estrogen Lynch Endometrioid adenocarcinoma PTEN Type II High grade More aggressive Serous, Clear Cell p53 Stage I IA IB Stage II Stage III IIIA IIIB IIIC IIIC1 IIIC2 Stage IV IVA IVB nodes

More information

Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0)

Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0) Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0) ** VALID ON DATE OF PRINTING ONLY all guidelines available on the Strategic Clinical Network website : GMLSC SCN Date first published

More information

ECC or Margins Positive?

ECC or Margins Positive? CLINICAL PRESENTATION This practice algorithm has been specifically developed for M. D. Anderson using a multidisciplinary approach and taking into consideration circumstances particular to M. D. Anderson,

More information

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE) ESTRO Teaching Course on Image-guided radiotherapy & chemotherapy in gynaecological cancer - With a special focus on adaptive brachytherapy Prague, Czech Republic 22-26 October 2017 Course Directors: Richard

More information

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA 2009 USCAP Gyn Pathology Evening Session Case #3 Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA rzaino@psu.edu Clinical history Middle aged woman with an exophytic mass of

More information

Invasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous

Invasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous Note: If available, clinical trials should be considered as preferred treatment options for eligible patients (www.mdanderson.org/gynonctrials). Other co-morbidities are taken into consideration prior

More information

Current staging of endometrial carcinoma with MR imaging

Current staging of endometrial carcinoma with MR imaging Current staging of endometrial carcinoma with MR imaging Poster No.: C-1436 Congress: ECR 2015 Type: Educational Exhibit Authors: M. Magalhaes, H. Donato, C. B. Marques, P. Gomes, F. Caseiro Alves; Coimbra/PT

More information

An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review of the Literature

An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review of the Literature Archives of Clinical and Medical Case Reports doi: 10.26502/acmcr.9655003 Volume 1, Issue 1 Case Report An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review

More information

Jacqui Morgan March 6, 2019

Jacqui Morgan March 6, 2019 Jacqui Morgan March 6, 2019 Case 1 25yo, G2P1 Here for WWE, no problems, healthy, needs refill on OCPs. Pap- Abnormal Glandular Cells-NOS Now What?? Case 1 Colposcopy What findings? Case 1 ECC Cervical

More information

ENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media

ENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media For mass reproduction, content licensing and permissions contact Dowden Health Media. UPDATE ENDOMETRIAL CANCER Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial

More information

INTRAUTERINE DEVICE = IUD INTRAUTERINE DEVICE = IUD CONGENITAL DISORDERS Pyometra = pyometrea is a uterine infection, it is accumulation of purulent material in the uterine cavity. Ultrasound is usually

More information

CERVIX MEASURE SPECIFICATIONS

CERVIX MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) CERVIX MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve

More information

Vagina. 1. Introduction. 1.1 General Information and Aetiology

Vagina. 1. Introduction. 1.1 General Information and Aetiology Vagina 1. Introduction 1.1 General Information and Aetiology The vagina is part of internal female reproductive system. It is an elastic, muscular tube that connects the outside of the body to the cervix.

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR Last Revision Date July 2015 1 Site Group: Gynecologic Cancer Vulvar Author: Dr. Stephane Laframboise 1. INTRODUCTION

More information

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

More information

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer Gynecologic Oncology Pre invasive vulvar, vaginal, & cervical disease Vulvar Cervical Endometrial Uterine Sarcoma Fallopian Tube Ovarian GTD Gynecologic Oncologist Surgery Chemotherapy Radiation Therapy

More information

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with

More information

Endometrial Stromal Sarcoma

Endometrial Stromal Sarcoma May 26, 2011 By Sushila Ladumor, MD [1] Endometrial stromal sarcoma (ESS) is a rare malignant tumor of the endometrium, occurring in the age group of 40-50 years. History The 50-year-old, female patient

More information

HYPERTHERMIA in CERVIX and VAGINA CANCER. J. van der Zee

HYPERTHERMIA in CERVIX and VAGINA CANCER. J. van der Zee HYPERTHERMIA in CERVIX and VAGINA CANCER J. van der Zee ESTRO 2006 Deep hyperthermia in Rotterdam HYPERTHERMIA in CERVIX and VAGINA CANCER ESTRO 2006 Hyperthermia and radiotherapy in primary advanced cervix

More information

Index. B Bilateral salpingo-oophorectomy (BSO), 69

Index. B Bilateral salpingo-oophorectomy (BSO), 69 A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell

More information

Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University

Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Cervical Cancer Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Estimated gynecologic cancer cases United States

More information

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas) C ORPUS UTERI C ARCINOMA STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery Tis * T1 I T1a IA NX N0 N1 N2

More information

Advanced Pelvic Malignancy: Defining Resectability Be Aggressive. Lloyd A. Mack September 19, 2015

Advanced Pelvic Malignancy: Defining Resectability Be Aggressive. Lloyd A. Mack September 19, 2015 Advanced Pelvic Malignancy: Defining Resectability Be Aggressive Lloyd A. Mack September 19, 2015 CONFLICT OF INTEREST DECLARATION I have no conflicts of interest Advanced Pelvic Malignancies Locally Advanced

More information

Prospective comparative study of dose dense neo-adjuvant chemotherapy followed by chemo-radiation and definitive chemoradiation

Prospective comparative study of dose dense neo-adjuvant chemotherapy followed by chemo-radiation and definitive chemoradiation International Journal of Reproduction, Contraception, Obstetrics and Gynecology Karpurmath SV et al. Int J Reprod Contracept Obstet Gynecol. 2016 Sept;5(9):2909-2914 www.ijrcog.org pissn 2320-1770 eissn

More information

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst Gynaecology Case Presentation Organ Imaging 2016 University of Toronto Sarah Johnson 39 year old female Clinical history: Assess right ovarian cyst Clinically diagnosed endometriosis Started fertility

More information

Torisel (temsirolimus)

Torisel (temsirolimus) Torisel (temsirolimus) Line(s) of Business: HMO; PPO; QUEST Integration Medicare Advantage Original Effective Date: 10/01/2015 Current Effective Date: 11/1/2017 POLICY A. INDICATIONS The indications below

More information

Locally advanced disease & challenges in management

Locally advanced disease & challenges in management Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervix Cancer Education Symposium, February 2018 Locally advanced disease & challenges in management Carien Creutzberg Radiation Oncology, Leiden

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

INTRODUCTION PATIENT. J. Radiat. Res., 52, (2011)

INTRODUCTION PATIENT. J. Radiat. Res., 52, (2011) J. Radiat. Res., 52, 54 58 (2011) Regular Paper Intracavitary Combined with CT-guided Interstitial Brachytherapy for Locally Advanced Uterine Cervical Cancer: Introduction of the Technique and a Case Presentation

More information

Post operative Radiotherapy in Carcinoma Endometrium - KMIO Experience (A Retrospective Study)

Post operative Radiotherapy in Carcinoma Endometrium - KMIO Experience (A Retrospective Study) Post operative Radiotherapy in Carcinoma Endometrium - KMIO Experience (A Retrospective Study) Sridhar.P, M.D. 1, Sruthi.K, M.D. 2, Naveen.T, M.D. 3, Siddanna.R.P, M.D. 4 Department of Radiation Oncology,

More information

Postoperative Radiotherapy for Patients with Invasive Cervical Cancer Following Treatment with Simple Hysterectomy

Postoperative Radiotherapy for Patients with Invasive Cervical Cancer Following Treatment with Simple Hysterectomy Jpn J Clin Oncol 2003;33(9)477 481 Postoperative Radiotherapy for Patients with Invasive Cervical Cancer Following Treatment with Simple Hysterectomy Shang-Wen Chen 1,2, Ji-An Liang 1,2, Shih-Neng Yang

More information

A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008

A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 NCT02432365 Chyong-Huey Lai, MD On behalf of Principal investigator

More information

Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer

Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer Arch Gynecol Obstet (2012) 285:811 816 DOI 10.1007/s00404-011-2038-z GYNECOLOGIC ONCOLOGY Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical

More information

FDG-PET/CT in Gynaecologic Cancers

FDG-PET/CT in Gynaecologic Cancers Friday, August 31, 2012 Session 6, 9:00-9:30 FDG-PET/CT in Gynaecologic Cancers (Uterine) cervical cancer Endometrial cancer & Uterine sarcomas Ovarian cancer Little mermaid (Edvard Eriksen 1913) honoring

More information

MRI Based treatment planning for with focus on prostate cancer. Xinglei Shen, MD Department of Radiation Oncology KUMC

MRI Based treatment planning for with focus on prostate cancer. Xinglei Shen, MD Department of Radiation Oncology KUMC MRI Based treatment planning for with focus on prostate cancer Xinglei Shen, MD Department of Radiation Oncology KUMC Overview How magnetic resonance imaging works (very simple version) Indications for

More information

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix. Uterine Cervix Protocol applies to all invasive carcinomas of the cervix. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition and FIGO 2001 Annual Report Procedures Cytology (No Accompanying

More information

Gynecologic Cancer InterGroup Cervix Cancer Research Network. The SHAPE Trial

Gynecologic Cancer InterGroup Cervix Cancer Research Network. The SHAPE Trial Gynecologic Cancer InterGroup Cervix Cancer Research Network The SHAPE Trial Comparing radical hysterectomy and pelvic node dissection against simple hysterectomy and pelvic node dissection in patients

More information

ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre)

ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) Source: UpToDate 2017, ASCO/CCO/Alberta provincial guidelines, NCCN Reviewed by: Dr. Sarah Glaze (Gynecologic

More information

Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals

Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals 6 Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 0-year Survivals V Sivanesaratnam,*FAMM, FRCOG, FACS Abstract Although the primary operative mortality following radical hysterectomy

More information

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs

More information

Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?

Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? e-issn 1643-3750 DOI: 10.12659/MSM.897291 Received: 2015.12.27 Accepted: 2016.01.13 Published: 2016.02.08 Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Authors Contribution:

More information

Uterus Malignancies /5/15

Uterus Malignancies /5/15 Collecting Cancer Data: Uterus 2014-2015 NAACCR Webinar Series February 5, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Uterine sarcoma. Information for patients Gynaecology

Uterine sarcoma. Information for patients Gynaecology Uterine sarcoma Information for patients Gynaecology page 2 of 12 This leaflet is intended to offer you support and information at a very difficult and stressful time in your life. To be told that you

More information

of surgical management of early invasive cervical cancer chapter Diagnosis and staging Wertheim described the principles

of surgical management of early invasive cervical cancer chapter Diagnosis and staging Wertheim described the principles chapter 14. Surgical management of early invasive cervical cancer CHAPTER 1 Wertheim described the principles of surgical management of invasive cervical cancer more than 100 years ago in his treatise

More information

Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive

Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive CANCER CERVIX Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive leison by PAP Smears. Etiology: Age - 2 peaks

More information

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE Case: Adenosarcoma with heterologous elements and stromal overgrowth o TAH, BSO, omentectomy, staging biopsies of cul-de-sac, bladder

More information